These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 1965508

  • 1. A phase II study on lonidamine combined with cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma (NSCBC).
    Lelli G, Guaraldi M, Canova N, Casadio M, Pannuti F.
    J Chemother; 1990 Dec; 2(6):401-4. PubMed ID: 1965508
    [Abstract] [Full Text] [Related]

  • 2. A phase III study on intermittent versus weekly cisplatin and etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
    Lelli G, Casadio M, Farris A, Tononi A, Giordani S, Pannuti F.
    J Chemother; 1989 Apr; 1(2):136-9. PubMed ID: 2659747
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma.
    Mazzei T, Marino C, Nozzoli F, Lopes-Pegna A, Righi R, Santomaggio C, Lamanna S, Periti P.
    Chemioterapia; 1984 Feb; 3(1):16-8. PubMed ID: 6100172
    [Abstract] [Full Text] [Related]

  • 4. Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
    Casadio M, Lelli G, Giordani S, Boltri B, Blotta A, Busutti L, Ramini R, Falcone F, Pannuti F.
    J Chemother; 1990 Jun; 2(3):199-202. PubMed ID: 2166145
    [Abstract] [Full Text] [Related]

  • 5. Phase II studies on weekly cisplatinum plus epirubicin or etoposide in the treatment of advanced non-small cell bronchogenic carcinoma.
    Lelli G, Casadio M, Giuliotti C, Giordani S, Martoni A, Strocchi E, Pannuti F.
    Chemioterapia; 1986 Aug; 5(4):228-31. PubMed ID: 3021346
    [Abstract] [Full Text] [Related]

  • 6. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
    Kucuk O, Shevrin DH, Pandya KJ, Bonomi PD.
    Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
    [Abstract] [Full Text] [Related]

  • 7. A phase I-II study of sequential infusion VP-16 and cisplatin therapy in advanced lung cancer.
    Krook JE, Jett JR, Little C.
    Am J Clin Oncol; 1989 Apr; 12(2):114-7. PubMed ID: 2539716
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK.
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [Abstract] [Full Text] [Related]

  • 9. [Results of drug therapy of inoperable non-small cell lung carcinoma with VP 16-213 (Etoposide) and cis-platin. A phase II study].
    Klippstein T, Graubner M, Berdel WE, Mende S, Gropp C, Diehl V, Mitrou PS.
    Onkologie; 1983 Dec; 6(6):306-11. PubMed ID: 6366676
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.
    Paccagnella A, Favaretto A, Brandes A, Ghiotto C, Fornasiero A, Volpi A, Pappagallo G, Festi G, Cipriani A, Vinante O.
    Cancer; 1990 Jun 15; 65(12):2631-4. PubMed ID: 2160312
    [Abstract] [Full Text] [Related]

  • 11. A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).
    Chang AY, Kim K, Boucher H, Bonomi P, Stewart JA, Karp DD, Blum RH.
    Cancer; 1998 Jan 15; 82(2):292-300. PubMed ID: 9445185
    [Abstract] [Full Text] [Related]

  • 12. [Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
    Drings P, Becker H, Bülzebruck H, Djawid N, Ruchalla E, Stiefel P, Tessen HW.
    Onkologie; 1988 Jan 15; 11 Suppl 2():47-56. PubMed ID: 2851761
    [Abstract] [Full Text] [Related]

  • 13. Cisplatin plus epirubicin and etoposide followed by irradiation plus lonidamine in stage III nonsmall cell lung cancer.
    Filipazzi V, Cattaneo MT, Rho B, Frontini L, D'Adda D, Isa L, Scapaticci R, Legnani W, Calzavara MP, Berni F.
    Oncology; 1993 Jan 15; 50(1):10-3. PubMed ID: 8380632
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
    Crino L, Tonato M, Darwish S, Meacci ML, Corgna E, Di Costanzo F, Buzzi F, Fornari G, Santi E, Ballatori E.
    Cancer Chemother Pharmacol; 1990 Jan 15; 26(1):52-6. PubMed ID: 2157554
    [Abstract] [Full Text] [Related]

  • 15. Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
    Shepherd FA, Evans WK, Goss PE, Latreille J, Logan D, Maroun J, Stewart D, Warner E, Paul K.
    Semin Oncol; 1992 Feb 15; 19(1 Suppl 1):54-8. PubMed ID: 1329213
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
    Klastersky J, Sculier JP, Bureau G, Libert P, Ravez P, Vandermoten G, Thiriaux J, Lecomte J, Cordier R, Dabouis G.
    J Clin Oncol; 1989 Aug 15; 7(8):1087-92. PubMed ID: 2547028
    [Abstract] [Full Text] [Related]

  • 17. A multicenter phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer.
    Splinter T, Kok T, Kho S, Lameris H, ten Kate F, Dalesio O, Dolman B, Palmen F, Bouvy J, Burghouts J.
    Semin Oncol; 1986 Sep 15; 13(3 Suppl 3):97-103. PubMed ID: 3020707
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.
    Semin Oncol; 1995 Dec 15; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [Abstract] [Full Text] [Related]

  • 19. European experience with ifosfamide in non-small cell lung cancer.
    Drings P.
    Semin Oncol; 1989 Feb 15; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.